Lung tissue bioengineering for chronic obstructive pulmonary disease: overcoming the need for lung transplantation from human donors

References

• Devereux G. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ. 2006;332:1142–1144.
   PubMed Web of Science ®Google Scholar
• GBD 2013. Mortality and causes of death collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–171.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Samet J, editor. PLOS Med. 2006;3:e442.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21:14–23.
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332:1202–1204.
   Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, McAlinden K, et al. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Sci Rep. 2017;7:13392.
   PubMed Web of Science ®Google Scholar
• Milara J, Serrano A, Gimeno JC, et al. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 2013;68:410-420.
   Google Scholar
• Courtney J-M, Spafford P, Sohal SS, et al. TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD. Eur Respir J. 2016;48:PA953.
   Web of Science ®Google Scholar
• Haidl P, Clement C, Wiese C, et al. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration. 2004;71:342–347.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Sue R, Wright S, et al. A multicenter randomized controlled Trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198:1151–1164.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073.
   PubMed Web of Science ®Google Scholar
• Lahzami S, Bridevaux PO, Soccal PM, et al. Survival impact of lung transplantation for COPD. Eur Respir J. 2010;36:74–80.
   PubMed Web of Science ®Google Scholar
• Hardy JD, Webb WR, Dalton ML Jr., et al. Lung homotransplantation in man: report of the initial case. Jama. 1963;186:1065–1074.
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013;143:1590–1598.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Paes JT, Bilaqui A, Greco OT, et al. Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis. 2011;6:63–71.
   PubMed Web of Science ®Google Scholar
• Stolk J, Broekman W, Mauad T, et al. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema. Qjm. 2016;109:331–336.
   PubMed Web of Science ®Google Scholar
• De Oliveira HG, Cruz FF, Antunes MA, et al. Combined bone marrow-derived mesenchymal stromal cell therapy and one-way endobronchial valve placement in patients with pulmonary emphysema: A phase i clinical trial. Stem Cells Transl Med. 2017;6:962–969.
   PubMed Web of Science ®Google Scholar
• Huang SXL, Islam MN, O’Neill J, et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014;32:84–91.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Ye X, Sun R, et al. Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo. Stem Cells Transl Med. 2014;3:675–685.
   PubMed Web of Science ®Google Scholar
• Wada H, Yoshida S, Suzuki H, et al. Transplantation of alveolar type II cells stimulates lung regeneration during compensatory lung growth in adult rats. J Thorac Cardiovasc Surg. 2012;143:711–719.e2.
   PubMed Web of Science ®Google Scholar
• Huang K, Kang X, Wang X, et al. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats. Mol Med Rep. 2015;11:1685–1692.
   PubMed Web of Science ®Google Scholar
• Yusen RD, Edwards LB, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35:1170–1184.
   PubMed Web of Science ®Google Scholar
• Thabut G, Mal H. Outcomes after lung transplantation. J Thorac Dis. 2017;9:2684–2691.
   PubMedGoogle Scholar
• Lambrigts D, Sachs DH, Cooper DK. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation. 1998;66:547–561.
   PubMed Web of Science ®Google Scholar
• Reemtsma K. Renal heterotransplantation from nonhuman primates to man. Ann N Y Acad Sci. 1969;162:412–418.
   PubMed Web of Science ®Google Scholar
• Rood PPM, Cooper DKC. Islet xenotransplantation: are we really ready for clinical trials? Am J Transplant. 2006;6:1269–1274.
   PubMed Web of Science ®Google Scholar
• Fink JS, Schumacher JM, Ellias SL, et al. Porcine xenografts in parkinson’s disease and huntington’s disease patients: preliminary results. Cell Transplant. 2000;9:273–278.
   PubMed Web of Science ®Google Scholar
• Bailey LL, Nehlsen-Cannarella SL, Concepcion W, et al. Baboon-to-human cardiac xenotransplantation in a neonate. Jama. 1985;254:3321–3329.
   PubMed Web of Science ®Google Scholar
• Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet. 1993;341:65–71.
   PubMed Web of Science ®Google Scholar
• Chatterjee DS. A controlled comparative study of the use of porcine xenograft in the treatment of partial thickness skin loss in an occupational health centre. Curr Med Res Opin. 1978;5:726–733.
   PubMed Web of Science ®Google Scholar
• Galili U. Discovery of the natural anti-Gal antibody and its past and future relevance to medicine. Xenotransplantation. 2013;20:138–147.
   PubMed Web of Science ®Google Scholar
• Pierson RN. Antibody-mediated xenograft injury: mechanisms and protective strategies. Transpl Immunol. 2009;21:65–69.
   PubMed Web of Science ®Google Scholar
• Galili U, Shohet SB, Kobrin E, et al. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem. 1988;263:17755–17762.
   PubMed Web of Science ®Google Scholar
• Azimzadeh AM, Kelishadi SS, Ezzelarab MB, et al. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein. Xenotransplantation. 2015;22:310–316.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Stawinski GV, Daggett CW, Lau CL, et al. Non-anti-gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg. 2002;194:765–773.
   PubMed Web of Science ®Google Scholar
• Song K-H, Kang Y-J, Jin U-H, et al. Cloning and functional characterization of pig CMP- N -acetylneuraminic acid hydroxylase for the synthesis of N -glycolylneuraminic acid as the xenoantigenic determinant in pig–human xenotransplantation. Biochem J. 2010;427:179–188.
   PubMed Web of Science ®Google Scholar
• Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation. 2013;20:27–35.
   PubMed Web of Science ®Google Scholar
• Galili U. Avoiding detrimental human immune response against mammalian extracellular matrix implants. Tissue Eng Part B Rev. 2015;21:231–241.
   PubMed Web of Science ®Google Scholar
• Cowan PJ, Hawthorne WJ, Nottle MB. Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9. Curr Opin Organ Transplant. 2018;24:1.
   Web of Science ®Google Scholar
• Klymiuk N, Aigner B, Brem G, et al. Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev. 2010;77:209–221.
   PubMed Web of Science ®Google Scholar
• Diamond LE, Quinn CM, Martin MJ, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation. 2001;71:132–142.
   PubMed Web of Science ®Google Scholar
• Daggett CW, Yeatman M, Lodge AJ, et al. Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. J Thorac Cardiovasc Surg. 1997;113:390–398.
   PubMed Web of Science ®Google Scholar
• Harris DG, Quinn KJ, French BM, et al. Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation. 2015;22:102–111.
   PubMed Web of Science ®Google Scholar
• Miyagawa S, Yamamoto A, Matsunami K, et al. Complement regulation in the GalT KO era. Xenotransplantation. 2010;17:11–25.
   PubMed Web of Science ®Google Scholar
• Cooper DKC, Ekser B, Burlak C, et al. Clinical lung xenotransplantation--what donor genetic modifications may be necessary? Xenotransplantation. 2012;19:144–158.
   PubMed Web of Science ®Google Scholar
• Gilpin SE, Ott HC. Using nature’s platform to engineer bio-artificial lungs. Ann Am Thorac Soc. 2015;12:S45–S49.
   PubMedGoogle Scholar
• Price AP, Godin LM, Domek A, et al. Automated decellularization of intact, human-sized lungs for tissue engineering. Tissue Eng Part C Methods. 2015;21:94–103.
   PubMed Web of Science ®Google Scholar
• Tsuchiya T, Mendez J, Calle EA, et al. Ventilation-based decellularization system of the lung. Biores Open Access. 2016;5:118–126.
   PubMed Web of Science ®Google Scholar
• Bonenfant NR, Sokocevic D, Wagner DE, et al. The effects of storage and sterilization on de-cellularized and re-cellularized whole lung. Biomaterials. 2013;34:3231–3245.
   PubMed Web of Science ®Google Scholar
• Nichols JE, La Francesca S, Vega SP, et al. Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs. J Tissue Eng Regen Med. 2017;11:2136–2152.
   PubMed Web of Science ®Google Scholar
• Nichols JE, Niles J, Riddle M, et al. Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng Part A. 2013;19:2045–2062.
   PubMed Web of Science ®Google Scholar
• Platz J, Bonenfant NR, Uhl FE, et al. Comparative decellularization and recellularization of wild-type and alpha 1,3 galactosyltransferase knockout pig lungs: a model for ex vivo xenogeneic lung bioengineering and transplantation. Tissue Eng Part C Methods. 2016;22:725–739.
   PubMed Web of Science ®Google Scholar
• Wong JY, Tait B, Levvey B, et al. Epstein-barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease. Transplantation. 2004;78:205–210.
   PubMed Web of Science ®Google Scholar
• Bonatti H, Tabarelli W, Ruttmann E, et al. Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg. 2004;70:710–714.
   PubMed Web of Science ®Google Scholar
• Scobie L, Takeuchi Y. Porcine endogenous retrovirus and other viruses in xenotransplantation. Curr Opin Organ Transplant. 2009;14:175–179.
   PubMed Web of Science ®Google Scholar
• Paradis K. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Sci. 1999;285:1236–1241.
   PubMed Web of Science ®Google Scholar
• Kimsa MC, Strzalka-Mrozik B, Kimsa MW, et al. Porcine endogenous retroviruses in xenotransplantation--molecular aspects. Viruses. 2014;6:2062–2083.
   PubMed Web of Science ®Google Scholar
• Nonaka PN, Campillo N, Uriarte JJ, et al. Effects of freezing/thawing on the mechanical properties of decellularized lungs. J Biomed Mater Res A. 2014;102:413–419.
   PubMed Web of Science ®Google Scholar
• Franks TJ, Colby TV, Travis WD, et al. Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc. 2008;5:763–766.
   PubMedGoogle Scholar
• Zhou H, Kitano K, Ren X, et al. Bioengineering human lung grafts on porcine matrix. Ann Surg. 2018;267:590–598.
   PubMed Web of Science ®Google Scholar
• Gilpin SE, Ren X, Okamoto T, et al. Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. Ann Thorac Surg. 2014;98:1721–1729, discussion 1729
   PubMed Web of Science ®Google Scholar
• Lwebuga-Mukasa JS, Ingbar DH, Madri JA. Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture. Exp Cell Res. 1986;162:423–435.
   PubMed Web of Science ®Google Scholar
• Lin Y-M, Zhang A, Rippon HJ, et al. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng Part A. 2010;16:1515–1526.
   PubMed Web of Science ®Google Scholar
• Sanchez-Esteban J, Cicchiello LA, Wang Y, et al. Mechanical stretch promotes alveolar epithelial type II cell differentiation. J Appl Physiol. 2001;91:589–595.
   PubMed Web of Science ®Google Scholar
• Faulk DM, Johnson SA, Zhang L, et al. Role of the extracellular matrix in whole organ engineering. J Cell Physiol. 2014;229:984–989.
   PubMed Web of Science ®Google Scholar
• Nichols JE, La Francesca S, Niles JA, et al. Production and transplantation of bioengineered lung into a large-animal model. Sci Transl Med. 2018;10:eaao3926.
   PubMed Web of Science ®Google Scholar
• Doi R, Tsuchiya T, Mitsutake N, et al. Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells. Sci Rep. 2017;7.
   Web of Science ®Google Scholar
• Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science. 2010;329:538–541.
   PubMed Web of Science ®Google Scholar
• Song JJ, Kim SS, Liu Z, et al. Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg. 2011;92:998–1006.
   PubMed Web of Science ®Google Scholar
• Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16:927–933.
   PubMed Web of Science ®Google Scholar
• Derakhshanfar S, Mbeleck R, Xu K, et al. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Bioact Mater. 2018;3:144–156.
   PubMed Web of Science ®Google Scholar
• Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32:773–785.
   PubMed Web of Science ®Google Scholar
• Hinton TJ, Jallerat Q, Palchesko RN, et al. Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels. Sci Adv. 2015;1:e1500758.
   PubMed Web of Science ®Google Scholar
• Wu W, Deconinck A, Lewis JA. Omnidirectional printing of 3D microvascular networks. Adv Mater. 2011;23:178–183.
   PubMed Web of Science ®Google Scholar
• Hockaday LA, Kang KH, Colangelo NW, et al. Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication. 2012;4:035005.
   PubMed Web of Science ®Google Scholar
• Miller JS, Stevens KR, Yang MT, et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater. 2012;11:768–774.
   PubMed Web of Science ®Google Scholar
• Park JY, Choi JC, Shim JH, et al. A comparative study on collagen type i and hyaluronic acid dependent cell behavior for osteochondral tissue bioprinting. Biofabrication. 2014;6:035004.
   PubMed Web of Science ®Google Scholar
• Berger J, Reist M, Mayer JM, et al. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm. 2004;57:19–34.
   PubMed Web of Science ®Google Scholar
• Jia J, Richards DJ, Pollard S, et al. Engineering alginate as bioink for bioprinting. Acta Biomater. 2014;10:4323–4331.
   PubMed Web of Science ®Google Scholar
• Billiet T, Gevaert E, De Schryver T, et al. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability. Biomaterials. 2014;35:49–62.
   PubMed Web of Science ®Google Scholar
• Pati F, Jang J, Ha D-H, et al. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun. 2014;5:3935.
   PubMed Web of Science ®Google Scholar
• You F, Wu X, Chen X. 3D printing of porous alginate/gelatin hydrogel scaffolds and their mechanical property characterization. Int J Polym Mater Polym Biomater. 2017;66:299–306.
   Web of Science ®Google Scholar
• Ifkovits JL, Burdick JA. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng. 2007;13:2369–2385.
   PubMedGoogle Scholar
• Grigoryan B, Paulsen SJ, Corbett DC, et al. Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Sci. 2019;364:458–464.
   PubMed Web of Science ®Google Scholar
• Lee JW, Choi YJ, Yong WJ, et al. Development of a 3D cell printed construct considering angiogenesis for liver tissue engineering. Biofabrication. 2016;8:015007.
   PubMed Web of Science ®Google Scholar
• Isaacson A, Swioklo S, Connon CJ. 3D bioprinting of a corneal stroma equivalent. Exp Eye Res. 2018;173:188–193.
   PubMed Web of Science ®Google Scholar
• Cubo N, Garcia M, Del Cañizo JF, et al. 3D bioprinting of functional human skin: production and in vivo analysis. Biofabrication. 2017;9:015006.
   Web of Science ®Google Scholar
• Townsend JM, Ott LM, Salash JR, et al. Reinforced electrospun polycaprolactone nanofibers for tracheal repair in an in vivo ovine model. Tissue Eng Part A. 2018;24:1301–1308.
   PubMed Web of Science ®Google Scholar
• Bae S-W, Lee K-W, Park J-H, et al. 3D bioprinted artificial trachea with epithelial cells and chondrogenic-differentiated bone marrow-derived mesenchymal stem cells. Int. J. Mol. Sci. 2018;19:E1624.
   Google Scholar
• Rehmani SS, Al-Ayoubi AM, Ayub A, et al. Three-dimensional-printed bioengineered tracheal grafts: preclinical results and potential for human use. Ann Thorac Surg. 2017;104:998–1004.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Sato H, Kato-Itoh M, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191–196.
   PubMed Web of Science ®Google Scholar
• Matsunari H, Nagashima H, Watanabe M, et al. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci. 2013;110:4557–4562.
   PubMed Web of Science ®Google Scholar
• Kimura S, Hara Y, Pineau T, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996;10:60–69.
   PubMed Web of Science ®Google Scholar
• Rockich BE, Hrycaj SM, Shih HP, et al. Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. Proc Natl Acad Sci U S A. 2013;110:E4456–64.
   PubMed Web of Science ®Google Scholar
• Hrycaj SM, Dye BR, Baker NC, et al. Hox5 genes regulate the Wnt2/2b-Bmp4-signaling axis during lung development. Cell Rep. 2015;12:903–912.
   PubMed Web of Science ®Google Scholar
• Que J, Luo X, Schwartz RJ, et al. Multiple roles for sox2 in the developing and adult mouse trachea. Development. 2009;136:1899–1907.
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90:121–127.
   PubMed Web of Science ®Google Scholar
• Panchabhai TS, Arrossi AV, Patil PD, et al. Unexpected neoplasms in lungs explanted from lung transplant recipients: a single-center experience and review of literature. Transplant. Proc. 2018;50:234–240.
   Google Scholar
• Serrano-Mollar A, Nacher M, Gay-Jordi G, et al. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2007;176:1261–1268.
   PubMed Web of Science ®Google Scholar
• Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19:193–204.
   PubMed Web of Science ®Google Scholar
• Rippon HJ, Polak JM, Qin M, et al. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells. 2006;24:1389–1398.
   PubMed Web of Science ®Google Scholar
• Wang D, Haviland DL, Burns AR, et al. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104:4449–4454.
   PubMed Web of Science ®Google Scholar
• Wang D, Morales JE, Calame DG, et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther. 2010;18:625–634.
   PubMed Web of Science ®Google Scholar
• Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133–158.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.
   PubMed Web of Science ®Google Scholar
• Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle. 2010;9:880–885.
   PubMed Web of Science ®Google Scholar
• Lin T, Wu S. Reprogramming with small molecules instead of exogenous transcription factors. Stem Cells Int. 2015;2015:1–11.
   Google Scholar
• Hu K. All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. Stem Cells Dev. 2014;23:1285–1300.
   PubMed Web of Science ®Google Scholar
• Seo B, Hong Y, Do J. Cellular reprogramming using protein and cell-penetrating peptides. Int J Mol Sci. 2017;18:552.
   Web of Science ®Google Scholar
• Gutz E. Measurement of the single polarization observables icand isin π0η photoproduction. AIP Conf Proc. 2010;1257:581–585.
   Google Scholar
• Yuhgetsu H, Ohno Y, Funaguchi N, et al. Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp Lung Res. 2006;32:413–426.
   PubMed Web of Science ®Google Scholar
• Liu A, Chen S, Cai S, et al. Wnt5a through noncanonical Wnt/JNK or Wnt/PKC signaling contributes to the differentiation of mesenchymal stem cells into type II alveolar epithelial cells in vitro. Rameshwar P, editor. PLoS One. 2014;9:e90229.
   PubMed Web of Science ®Google Scholar
• Guan X-J, Song L, Han -F-F, et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem. 2013;114:323–335.
   PubMed Web of Science ®Google Scholar
• Kim Y-S, Kim J-Y, Shin D-M, et al. Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysema. Tuberc Respir Dis (Seoul). 2014;77:116–123.
   PubMedGoogle Scholar
• Gu W, Song L, Li X-M, et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015;5:8733.
   PubMed Web of Science ®Google Scholar
• Wecht S, Rojas M. Mesenchymal stem cells in the treatment of chronic lung disease. Respirology. 2016;21:1366–1375.
   PubMedGoogle Scholar
• Katsha AM, Ohkouchi S, Xin H, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 2011;19:196–203.
   PubMed Web of Science ®Google Scholar
• Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32:252–260.
   PubMed Web of Science ®Google Scholar
• Stessuk T, Ruiz MA, Greco OT, et al. Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Rev Bras Hematol Hemoter. 2013;35:352–359.
   PubMedGoogle Scholar
• Ikonomou L, Freishtat RJ, Wagner DE, et al. The global emergence of unregulated stem cell treatments for respiratory diseases. Professional societies need to act. Ann Am Thorac Soc. 2016;13:1205–1207.
   PubMed Web of Science ®Google Scholar
• Kuriyan AE, Albini TA, Townsend JH, et al. Vision loss after intravitreal injection of autologous “Stem Cells” for AMD. N Engl J Med. 2017;376:1047–1053.
   PubMed Web of Science ®Google Scholar
• Berkowitz AL, Miller MB, Mir SA, et al. Glioproliferative lesion of the spinal cord as a complication of “Stem-Cell Tourism”. N Engl J Med. 2016;375:196–198.
   PubMed Web of Science ®Google Scholar
• Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. Fischer A, editor. PLOS Med. 2009;6:e1000029.
   PubMed Web of Science ®Google Scholar